Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia

Ofir Haramati, Revital Mane, Gabriela Molczadzki, J. Regino Perez-Polo, Vered Chalifa-Caspi, Hava M. Golan

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Prenatal perturbation of brain circulation and oxygenation is a leading cause of perinatal brain damage affecting about 0.3-0.9% of births. Hypoxia-ischemia (HI) in preterm human infants at gestational week 23-32 results in neurodevelopmental abnormalities in childhood, presenting as learning disability, seizure activity, motor impairment and in the most severe cases, death. Here, we examined the potential of MgSO4 treatment, prior to foetal hypoxia, to attenuate hypoxia induced damage in a murine model of maternal hypoxia. We studied the time course of maternal hypoxia and MgSO4 pre-treatment effects on cerebellar tissue by means of DNA microarray analyses. Mild hypoxia induced minor expression changes in most genes. However, there were 5 gene sets which were down-regulated by maternal hypoxia. MgSO4 pre-treatment abrogated these decreases in gene. A cell cycle gene set which responded immediately (2 h) to hypoxia, showed a delayed response (24 h) when MgSO4 pre-treatment was given. Similar proportions of cell death were observed in all groups before P7, where combined hypoxia and MgSO4 treatment increased cell death in the internal granule layer. There were a higher number of BrdU positive cells at the end of hypoxic episodes and a down-regulation of Reelin signaling, compared to control. MgSO4 pre-treatment prevented the enhancement of cell proliferation due to hypoxia and increased Reelin levels. Altogether, MgSO4 pre-treatment both reduced the number of genes differentially affected by hypoxia and delayed the responses to hypoxia. In addition, MgSO4 pre-treatment modified the nature of the transcriptional response; while hypoxia induced down-regulation of gene sets, MgSO4 pre-treatment mostly up-regulated them. The dual reaction to the MgSO4 treatment may be the source of the ambiguity in observations reported for affected newborns.

    Original languageEnglish (US)
    Pages (from-to)207-216
    Number of pages10
    JournalInternational Journal of Developmental Neuroscience
    Volume28
    Issue number2
    DOIs
    StatePublished - Apr 2010

    Fingerprint

    Magnesium Sulfate
    Gene Expression
    Therapeutics
    Genes
    Mothers
    Hypoxia
    Cell Death
    Down-Regulation
    Fetal Hypoxia
    cdc Genes
    Learning Disorders
    Brain
    Bromodeoxyuridine
    Microarray Analysis
    Oligonucleotide Array Sequence Analysis
    Premature Infants
    Seizures
    Motor Activity
    Ischemia

    Keywords

    • Dab1
    • Hypoxia
    • Magnesium sulfate
    • Neurogenesis
    • Reelin

    ASJC Scopus subject areas

    • Developmental Biology
    • Developmental Neuroscience

    Cite this

    Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia. / Haramati, Ofir; Mane, Revital; Molczadzki, Gabriela; Perez-Polo, J. Regino; Chalifa-Caspi, Vered; Golan, Hava M.

    In: International Journal of Developmental Neuroscience, Vol. 28, No. 2, 04.2010, p. 207-216.

    Research output: Contribution to journalArticle

    Haramati, Ofir ; Mane, Revital ; Molczadzki, Gabriela ; Perez-Polo, J. Regino ; Chalifa-Caspi, Vered ; Golan, Hava M. / Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia. In: International Journal of Developmental Neuroscience. 2010 ; Vol. 28, No. 2. pp. 207-216.
    @article{f4b3f2a1dbdc43198f3805e1616d7d2a,
    title = "Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia",
    abstract = "Prenatal perturbation of brain circulation and oxygenation is a leading cause of perinatal brain damage affecting about 0.3-0.9{\%} of births. Hypoxia-ischemia (HI) in preterm human infants at gestational week 23-32 results in neurodevelopmental abnormalities in childhood, presenting as learning disability, seizure activity, motor impairment and in the most severe cases, death. Here, we examined the potential of MgSO4 treatment, prior to foetal hypoxia, to attenuate hypoxia induced damage in a murine model of maternal hypoxia. We studied the time course of maternal hypoxia and MgSO4 pre-treatment effects on cerebellar tissue by means of DNA microarray analyses. Mild hypoxia induced minor expression changes in most genes. However, there were 5 gene sets which were down-regulated by maternal hypoxia. MgSO4 pre-treatment abrogated these decreases in gene. A cell cycle gene set which responded immediately (2 h) to hypoxia, showed a delayed response (24 h) when MgSO4 pre-treatment was given. Similar proportions of cell death were observed in all groups before P7, where combined hypoxia and MgSO4 treatment increased cell death in the internal granule layer. There were a higher number of BrdU positive cells at the end of hypoxic episodes and a down-regulation of Reelin signaling, compared to control. MgSO4 pre-treatment prevented the enhancement of cell proliferation due to hypoxia and increased Reelin levels. Altogether, MgSO4 pre-treatment both reduced the number of genes differentially affected by hypoxia and delayed the responses to hypoxia. In addition, MgSO4 pre-treatment modified the nature of the transcriptional response; while hypoxia induced down-regulation of gene sets, MgSO4 pre-treatment mostly up-regulated them. The dual reaction to the MgSO4 treatment may be the source of the ambiguity in observations reported for affected newborns.",
    keywords = "Dab1, Hypoxia, Magnesium sulfate, Neurogenesis, Reelin",
    author = "Ofir Haramati and Revital Mane and Gabriela Molczadzki and Perez-Polo, {J. Regino} and Vered Chalifa-Caspi and Golan, {Hava M.}",
    year = "2010",
    month = "4",
    doi = "10.1016/j.ijdevneu.2009.11.001",
    language = "English (US)",
    volume = "28",
    pages = "207--216",
    journal = "International Journal of Developmental Neuroscience",
    issn = "0736-5748",
    publisher = "Elsevier Limited",
    number = "2",

    }

    TY - JOUR

    T1 - Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia

    AU - Haramati, Ofir

    AU - Mane, Revital

    AU - Molczadzki, Gabriela

    AU - Perez-Polo, J. Regino

    AU - Chalifa-Caspi, Vered

    AU - Golan, Hava M.

    PY - 2010/4

    Y1 - 2010/4

    N2 - Prenatal perturbation of brain circulation and oxygenation is a leading cause of perinatal brain damage affecting about 0.3-0.9% of births. Hypoxia-ischemia (HI) in preterm human infants at gestational week 23-32 results in neurodevelopmental abnormalities in childhood, presenting as learning disability, seizure activity, motor impairment and in the most severe cases, death. Here, we examined the potential of MgSO4 treatment, prior to foetal hypoxia, to attenuate hypoxia induced damage in a murine model of maternal hypoxia. We studied the time course of maternal hypoxia and MgSO4 pre-treatment effects on cerebellar tissue by means of DNA microarray analyses. Mild hypoxia induced minor expression changes in most genes. However, there were 5 gene sets which were down-regulated by maternal hypoxia. MgSO4 pre-treatment abrogated these decreases in gene. A cell cycle gene set which responded immediately (2 h) to hypoxia, showed a delayed response (24 h) when MgSO4 pre-treatment was given. Similar proportions of cell death were observed in all groups before P7, where combined hypoxia and MgSO4 treatment increased cell death in the internal granule layer. There were a higher number of BrdU positive cells at the end of hypoxic episodes and a down-regulation of Reelin signaling, compared to control. MgSO4 pre-treatment prevented the enhancement of cell proliferation due to hypoxia and increased Reelin levels. Altogether, MgSO4 pre-treatment both reduced the number of genes differentially affected by hypoxia and delayed the responses to hypoxia. In addition, MgSO4 pre-treatment modified the nature of the transcriptional response; while hypoxia induced down-regulation of gene sets, MgSO4 pre-treatment mostly up-regulated them. The dual reaction to the MgSO4 treatment may be the source of the ambiguity in observations reported for affected newborns.

    AB - Prenatal perturbation of brain circulation and oxygenation is a leading cause of perinatal brain damage affecting about 0.3-0.9% of births. Hypoxia-ischemia (HI) in preterm human infants at gestational week 23-32 results in neurodevelopmental abnormalities in childhood, presenting as learning disability, seizure activity, motor impairment and in the most severe cases, death. Here, we examined the potential of MgSO4 treatment, prior to foetal hypoxia, to attenuate hypoxia induced damage in a murine model of maternal hypoxia. We studied the time course of maternal hypoxia and MgSO4 pre-treatment effects on cerebellar tissue by means of DNA microarray analyses. Mild hypoxia induced minor expression changes in most genes. However, there were 5 gene sets which were down-regulated by maternal hypoxia. MgSO4 pre-treatment abrogated these decreases in gene. A cell cycle gene set which responded immediately (2 h) to hypoxia, showed a delayed response (24 h) when MgSO4 pre-treatment was given. Similar proportions of cell death were observed in all groups before P7, where combined hypoxia and MgSO4 treatment increased cell death in the internal granule layer. There were a higher number of BrdU positive cells at the end of hypoxic episodes and a down-regulation of Reelin signaling, compared to control. MgSO4 pre-treatment prevented the enhancement of cell proliferation due to hypoxia and increased Reelin levels. Altogether, MgSO4 pre-treatment both reduced the number of genes differentially affected by hypoxia and delayed the responses to hypoxia. In addition, MgSO4 pre-treatment modified the nature of the transcriptional response; while hypoxia induced down-regulation of gene sets, MgSO4 pre-treatment mostly up-regulated them. The dual reaction to the MgSO4 treatment may be the source of the ambiguity in observations reported for affected newborns.

    KW - Dab1

    KW - Hypoxia

    KW - Magnesium sulfate

    KW - Neurogenesis

    KW - Reelin

    UR - http://www.scopus.com/inward/record.url?scp=77649187444&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77649187444&partnerID=8YFLogxK

    U2 - 10.1016/j.ijdevneu.2009.11.001

    DO - 10.1016/j.ijdevneu.2009.11.001

    M3 - Article

    VL - 28

    SP - 207

    EP - 216

    JO - International Journal of Developmental Neuroscience

    JF - International Journal of Developmental Neuroscience

    SN - 0736-5748

    IS - 2

    ER -